Profile for badliechoperneute
|
Signature10 - 15 Based on existing data, trental 600 mg a rilascio modificato fluoroquinolone exposure during human gestation is not associated with increased risk of major malformations, adverse effects in the fetal musculoskeletal system, spontaneous abortions, prematurity, intrauterine growth retardation...
|
